MedPath

Study on proper use of the incretin related drugs and effects on renal function.

Not Applicable
Conditions
type 2 diabetes
Registration Number
JPRN-UMIN000031821
Lead Sponsor
Division of Nephrology, Endocrinology and Metabolism, Tokai University Scho ol of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Cases in which the test results were lost due to the transfer.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eGFR change
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath